These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21788418)

  • 21. Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy.
    Falcone M; Perilli M; Mezzatesta ML; Mancini C; Amicosante G; Stefani S; Venditti M
    Clin Microbiol Infect; 2010 Feb; 16(2):179-81. PubMed ID: 19624511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of a multiplex polymerase chain reaction assay to detect IMP-27 in a clinical isolate of Morganella morganii.
    Walkty A; Adam H; Tran V; Alexander DC; Boyd D; Bharat A; Karlowsky J
    Diagn Microbiol Infect Dis; 2018 Nov; 92(3):194-195. PubMed ID: 30025967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salicylate decreases production of AmpC type beta-lactamases and increases susceptibility to beta-lactams in a Morganella morganii clinical isolate.
    Tavío MM; Perilli M; Vila J; Becerro P; Casañas L; Amicosante G; Jiménez de Anta MT
    FEMS Microbiol Lett; 2004 Sep; 238(1):139-44. PubMed ID: 15336414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of KPC-2 and qnrS1 in clinical isolates of Morganella morganii from China.
    Cai JC; Yang W; Hu YY; Zhang R; Zhou HW; Chen GX
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):207-9. PubMed ID: 22542894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEB-6 extended-spectrum beta-lactamase-producing Proteus mirabilis from Sultanate of Oman.
    Potron A; Poirel L; Elhag K; Al Yaqoubi F; Nordmann P
    Int J Antimicrob Agents; 2009 Nov; 34(5):493-4. PubMed ID: 19525094
    [No Abstract]   [Full Text] [Related]  

  • 26. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
    Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of CMY-type beta-lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area.
    Decré D; Verdet C; Raskine L; Blanchard H; Burghoffer B; Philippon A; Sanson-Le-Pors MJ; Petit JC; Arlet G
    J Antimicrob Chemother; 2002 Nov; 50(5):681-8. PubMed ID: 12407124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India.
    Bhattacharya D; Thamizhmani R; Bhattacharya H; Sayi DS; Muruganandam N; Roy S; Sugunan AP
    Microb Drug Resist; 2013 Dec; 19(6):457-62. PubMed ID: 23862639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.
    Protonotariou E; Poulou A; Politi L; Meletis G; Chatzopoulou F; Malousi A; Metallidis S; Tsakris A; Skoura L
    Int J Antimicrob Agents; 2020 Aug; 56(2):106060. PubMed ID: 32574790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of extended-spectrum β-lactamase, AmpC, and carbapenemase production in Proteus mirabilis.
    Datta P; Gupta V; Arora S; Garg S; Chander J
    Jpn J Infect Dis; 2014; 67(1):44-6. PubMed ID: 24451101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Proteus mirabilis isolates in Taiwan.
    Huang CW; Chien JH; Peng RY; Tsai DJ; Li MH; Lee HM; Lin CF; Lee MC; Liao CT
    Int J Antimicrob Agents; 2015 Jan; 45(1):84-5. PubMed ID: 25446905
    [No Abstract]   [Full Text] [Related]  

  • 32. First description of DHA-1 ampCbeta-lactamase in Proteus mirabilis.
    Bidet P; Verdet C; Gautier V; Bingen E; Arlet G
    Clin Microbiol Infect; 2005 Jul; 11(7):591-2. PubMed ID: 15966982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outbreak caused by Proteus mirabilis isolates producing weakly expressed TEM-derived extended-spectrum β-lactamase in spinal cord injury patients with recurrent bacteriuria.
    Cremet L; Bemer P; Rome J; Juvin ME; Navas D; Bourigault C; Guillouzouic A; Caroff N; Lepelletier D; Asseray N; Perrouin-Verbe B; Corvec S
    Scand J Infect Dis; 2011 Dec; 43(11-12):957-61. PubMed ID: 21888562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serious nosocomial infection caused by Morganella morganii and Proteus mirabilis in a cardiac surgery unit.
    Williams EW; Hawkey PM; Penner JL; Senior BW; Barton LJ
    J Clin Microbiol; 1983 Jul; 18(1):5-9. PubMed ID: 6350354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Treatment of Bacteremia Due to NDM-1-Producing
    Hobson CA; Bonacorsi S; Fahd M; Baruchel A; Cointe A; Poey N; Jacquier H; Doit C; Monjault A; Tenaillon O; Birgy A
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530600
    [No Abstract]   [Full Text] [Related]  

  • 36. F2:A-:B- plasmid carrying the extended-spectrum β-lactamase bla(CTX-M-55/57) gene in Proteus mirabilis isolated from a primate.
    Dahmen S; Madec JY; Haenni M
    Int J Antimicrob Agents; 2013 Jun; 41(6):594-5. PubMed ID: 23507413
    [No Abstract]   [Full Text] [Related]  

  • 37. Early onset Morganella morganii sepsis in a newborn infant with emergence of cephalosporin resistance caused by depression of AMPC beta-lactamase production.
    Sinha AK; Kempley ST; Price E; Sharma BK; Livermore DM
    Pediatr Infect Dis J; 2006 Apr; 25(4):376-7. PubMed ID: 16567997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of bla KPC-2 on different plasmids of three Morganella morganii isolates.
    Shi DS; Wang WP; Kuai SG; Shao HF; Huang M
    Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):797-803. PubMed ID: 21874606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare Detection of the Acinetobacter Class D Carbapenemase blaOXA-23 Gene in Proteus mirabilis.
    Österblad M; Karah N; Halkilahti J; Sarkkinen H; Uhlin BE; Jalava J
    Antimicrob Agents Chemother; 2016 May; 60(5):3243-5. PubMed ID: 26902769
    [No Abstract]   [Full Text] [Related]  

  • 40. CTX-M-1 extended-spectrum beta-lactamase-producing Proteus mirabilis in Greece.
    Karapavlidou P; Sofianou D; Manolis EN; Pournaras S; Tsakris A
    Microb Drug Resist; 2005; 11(4):351-4. PubMed ID: 16359194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.